Simple jQuery Dropdowns

Browsing by Author Viseth Ngauy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-Apr-2018Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizationsSiriwat Akapirat; Chitraporn Karnasuta; Sandhya Vasan; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sirinan Madnote; Hathairat Savadsuk; Surawach Rittiroongrad; Jiraporn Puangkaew; Sanjay Phogat; James Tartaglia; Faruk Sinangil; Mark S. de Souza; Jean Louis Excler; Jerome H. Kim; Merlin L. Robb; Nelson L. Michael; Viseth Ngauy; Robert J. O’Connell; Nicos Karasavvas; International Vaccine Institute, Seoul; National Institute of Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; HJF; Walter Reed Army Institute of Research; Mahidol University; Thai Red Cross AIDS Research Centre; Global Solutions for Infectious Diseases; Sanofi Pasteur
15-Apr-2013Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm; Robert M. Paris; Supamit Chunsutthiwat; Nakorn Premsri; Chawetsan Namwat; Chureeratana Bowonwatanuwong; Shuying S. Li; Jaranit Kaewkungkal; Rapee Trichavaroj; Nampueng Churikanont; Mark S. De Souza; Charla Andrews; Donald Francis; Elizabeth Adams; Jorge Flores; Sanjay Gurunathan; Jim Tartaglia; Robert J. O'Connell; Chirapa Eamsila; Sorachai Nitayaphan; Viseth Ngauy; Prasert Thongcharoen; Prayura Kunasol; Nelson L. Michael; Merlin L. Robb; Peter B. Gilbert; Jerome H. Kim; Thailand Ministry of Public Health; US Military HIV Research Program; Chonburi Regional Hospital; Fred Hutchinson Cancer Research Center; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Royal Thai Army
1-Nov-2015IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas; Chitraporn Karnasuta; Hathairat Savadsuk; Sirinan Madnote; Dutsadee Inthawong; Somsak Chantakulkij; Surawach Rittiroongrad; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Vinai Siriyanon; Charla A. Andrews; Susan W. Barnett; James Tartaglia; Faruk Sinangil; Donald P. Francis; Merlin L. Robb; Nelson L. Michael; Viseth Ngauy; Mark S. De Souza; Robert M. Paris; Jean Louis Excler; Jerome H. Kim; Robert J. O'Connell; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Chiang Mai University; TECHNICAL RESOURCES INTERNATIONAL, INC.; NOVARTIS VACCINES AND DIAGNOSTICS, INC.; Sanofi Pasteur; Global Solutions for Infectious Diseases; Walter Reed Army Institute of Research; HJF; International Vaccine Institute, Seoul
5-Apr-2012Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F. Haynes; Peter B. Gilbert; M. Juliana McElrath; Susan Zolla-Pazner; Georgia D. Tomaras; S. Munir Alam; David T. Evans; David C. Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua Xin Liao; Anthony L. DeVico; George K. Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L. Robb; Viseth Ngauy; Mark S. De Souza; Robert Paris; Guido Ferrari; Robert T. Bailer; Kelly A. Soderberg; Charla Andrews; Phillip W. Berman; Nicole Frahm; Stephen C. De Rosa; Michael D. Alpert; Nicole L. Yates; Xiaoying Shen; Richard A. Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; NYU School of Medicine; Harvard Medical School; Walter Reed Army Institute of Research; National Institute of Allergy and Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Royal Thai Army; Faculty of Medicine, Siriraj Hospital, Mahidol University; Mahidol University; Thailand Ministry of Public Health; University of California, Santa Cruz; University of Maryland School of Medicine; Rutgers New Jersey Medical School
1-Apr-2020Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum; Sorachai Nitayaphan; Suwat Chariyalertsak; Jaranit Kaewkungwal; Peter Dawson; Jittima Dhitavat; Benjaluck Phonrat; Siriwat Akapirat; Nicos Karasavvas; Lindsay Wieczorek; Victoria Polonis; Michael A. Eller; Poonam Pegu; Dohoon Kim; Alexandra Schuetz; Surat Jongrakthaitae; Yingjun Zhou; Faruk Sinangil; Sanjay Phogat; Carlos A. Diazgranados; James Tartaglia; Elizabeth Heger; Kirsten Smith; Nelson L. Michael; Jean Louis Excler; Merlin L. Robb; Jerome H. Kim; Robert J. O'Connell; Sandhya Vasan; Arom Pitisuthitham; Yupa Sabmee; Narongrid Sirisopana; Chirapa Eamsila; Prapaporn Savaraj; Wanlaya Labwech; Siriluck Teerachia; Nuntisa Chotirosniramit; Taweewat Supindham; Boonlure Pruenglampoo; Patcharaphan Sugandhavesa; Natthapol Kosashunhanan; Oranitcha Kaewthip; Piyathida Sroysuwan; Pawinee Jarujareet; Silvia Ratto-Kim; Sebastian Molnar; Jesse Schoen; Nampueng Churikanont; Saowanit Getchalarat; Nongluck Sangnoi; Bessara Nuntapinit; Anant Phramtong; Pornsuk V. Grandin; Sirinan Madnote; Surawach Rittiroongrad; Boot Kaewboon; Rapee Trichavaroj; Jiraporn Puangkaew; Somsak Chantakulkij; Phiromrat Rakyat; Pornchanok Panjapornsuk; Nipattra Tragonlugsana; Weerawan Chuenarom; Mark de Souza; Viseth Ngauy; Nittaya Phanuphak; Nitiya Chomchey; Puttachard Saengtawan; Nipat Teeratakulpisarn; Rungsun Rerknimitr; Eugene Kroon; Carter A. Lee; Suchada Chinaworapong; GlaxoSmithKline SpA; International Vaccine Institute, Seoul; Sanofi Pasteur SA; The EMMES Corporation; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; Mahidol University; Chiang Mai University; US Army Medical Materiel Development Activity; Global Solutions for Infectious Diseases
9-Dec-2010Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia ankara-HIV-1 vaccine candidateJeffrey R. Currier; Viseth Ngauy; Mark S. de Souza; Silvia Ratto-Kim; Josephine H. Cox; Victoria R. Polonis; Patricia Earl; Bernard Moss; Sheila Peel; Bonnie Slike; Somchai Sriplienchan; Prasert Thongcharoen; Robert M. Paris; Merlin L. Robb; Jerome Kim; Nelson L. Michael; Mary A. Marovich; US MIlitary HIV Research Program/Henry M. Jackson Foundation; Armed Forces Research Institute of Medical Sciences, Thailand; International AIDS Vaccine Initiative; National Institute of Allergy and Infectious Diseases; Mahidol University
1-Nov-2012The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; NYU School of Medicine; Veterans Affairs NY Harbor Healthcare System; National Institute of Allergy and Infectious Diseases; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; Thailand Ministry of Public Health; Mahidol University; Walter Reed National Military Medical Center; Sanofi Pasteur; Global Solutions for Infectious Diseases; Los Alamos National Laboratory
15-May-2012The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S. De Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M. Paris; Jaranit Kaewkungwal; Nelson L. Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R. Currier; Jerome H. Kim; Supamit Chunsuttiwat; Nakorn Premsri; Chawetsan Namwat; Prayura Kunasol; Prasert Thongcharoen; Chirasak Khamboonruang; Valai Bussaratid; Wirach Maek-a-nantawat; Jittima Dhitavat; Pravan Suntharasamai; Swangjai Pungpak; Siriwan Vanijanonta; Jaranit Kaewkunwal; Amnat Khamsiriwatchara; Pawinee Jarujareet; Chirapa Easmila; Suchana Tabprasit; Viseth Ngauy; Robert Paris; Michael Benenson; Patricia Morgan; Arthur Brown; Mark De Souza; Rapee Trichavaroj; Nusara Thaitawat; Kanyasiri Kongnonkok; Boot Keawboon; Yuwadee Phuang-Ngern; Susan Mason; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Robin Harkness; Claude Meric; Lynn Baglyos; Raphaelle El Habib; Don Francis; Carter Lee; Elizabeth Adams; Merlin L. Robb; Mark Milazzo; Amy Bolen; Beryl Wessner; Jeffrey Currier; Deborah L. Birx; Don Stablein; Terry Germanson; Len Dally; Jean Louis Excler; Jeffrey Berenberg; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; Sanofi Pasteur; Sanofi Pasteur; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; U.S. Army Medical Research and Materiel Command; Centers for Disease Control and Prevention; The EMMES Corporation; International AIDS Vaccine Initiative; Tripler Regional Med Center